| zhao, hongru |
| Recruiting | 3 | 2100 | Europe, Canada, Japan, US, RoW | Rimegepant/BHV3000, Matching placebo | Pfizer | Pediatric Migraine | 01/29 | 01/29 | | |
| Xue, Sheng-Li |
NCT06379360: Maintenance Therapy of Hypomethylating Agent (HMA) in Favorable Risk Acute Myeloid Leukemia (AML) Patients |
|
|
| Recruiting | 2 | 77 | RoW | Hypomethylating agent, Azacitidine or Decitabine, Hypomethylating agent (HMA) | The First Affiliated Hospital of Soochow University | Acute Myeloid Leukemia | 12/25 | 12/28 | | |
| Recruiting | 2 | 25 | RoW | Venetoclax combined with azacitidine regimen | The First Affiliated Hospital of Soochow University, Jining Medical University, The Second People's Hospital of Huai'an, First Affiliated Hospital Bengbu Medical College, Northern Jiangsu People's Hospital, Affiliated Hospital of Nantong University, Suzhou Hospital of Traditional Chinese Medicine | Acute T-Lymphocytic Leukemia | 12/24 | 12/24 | | |
NCT06220162: VAC Regimen for AML Patients Who Failed to Response to VA Regimen |
|
|
| Recruiting | 2 | 32 | RoW | chidamide in combination with venetoclax and azacitidine (VAC) | The First Affiliated Hospital of Soochow University, Jining Medical University, The Second People's Hospital of Huai'an, First Affiliated Hospital Bengbu Medical College, Northern Jiangsu People's Hospital, Affiliated Hospital of Nantong University | Acute Myeloid Leukemia | 12/26 | 12/26 | | |
NCT05376111: Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients |
|
|
| Recruiting | 2 | 28 | RoW | Venetoclax, Azacitidine | The First Affiliated Hospital of Soochow University, Jining Medical University, The Second People's Hospital of Huai'an, First Affiliated Hospital Bengbu Medical College, Northern Jiangsu People's Hospital, Affiliated Hospital of Nantong University, Suzhou Hospital of Traditional Chinese Medicine | T-cell Acute Lymphoblastic Leukemia, Recruiting | 12/25 | 12/25 | | |
NCT06532552: Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia |
|
|
| Recruiting | 2 | 172 | RoW | VACl, Venetoclax+Azacitidine+Cladribine, VACh, Venetoclax+Azacitidine+Chidamide, VACl Alternating With VACh, Venetoclax+Azacitidine+Cladribine alternating with Venetoclax+Azacitidine+Chidamide, VA, Venetoclax+Azacitidine | The First Affiliated Hospital of Soochow University, Jining Medical University, Qilu Hospital of Shandong University, The Affiliated Hospital of Qingdao University, The First Affiliated Hospital of Anhui Medical University, Tongji Hospital, First Affiliated Hospital Bengbu Medical College | Acute Myeloid Leukemia, Adult, Newly Diagnosed | 08/27 | 08/28 | | |
NCT05566054: Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia |
|
|
| Recruiting | 2 | 92 | RoW | Chidamide, Azacitidine, Venetoclax | The First Affiliated Hospital of Soochow University, Jining Medical University, The Second People's Hospital of Huai'an, First Affiliated Hospital Bengbu Medical College, Northern Jiangsu Province People's Hospital, Affiliated Hospital of Nantong University, Suzhou Hospital of Traditional Chinese Medicine, Taizhou University | Acute Monocytic Leukemia, Newly Diagnosed | 09/24 | 09/25 | | |
| Recruiting | 2 | 48 | RoW | CAV regimen bridging to HSCT | The First Affiliated Hospital of Soochow University, The Second People's Hospital of Huai'an | Acute Leukemia, Relapsed, Acute Leukemia Refractory | 10/24 | 10/24 | | |
| Recruiting | 2 | 68 | RoW | CAV Regimen, MEC Regimen | The First Affiliated Hospital of Soochow University, The Second People's Hospital of Huai'an, First Affiliated Hospital Bengbu Medical College, Northern Jiangsu People's Hospital, Affiliated Hospital of Nantong University, Suzhou Hospital of Traditional Chinese Medicine, Jining Medical University | Acute Myeloid Leukemia | 10/24 | 10/24 | | |
NCT05901974: Venetoclax Combined With Azactidine in the Treatment of ALAL |
|
|
| Recruiting | 2 | 22 | RoW | Venetoclax, azactidine | Sheng-Li Xue, MD, Jining Medical University, The Second People's Hospital of Huai'an, First Affiliated Hospital Bengbu Medical College, Affiliated Hospital of Nantong University, Suzhou Hospital of Traditional Chinese Medicine, Northern Jiangsu People's Hospital | Acute Leukemia of Ambiguous Lineage | 07/25 | 07/25 | | |
NCT05940961: Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL |
|
|
| Recruiting | 2 | 42 | RoW | Inotuzumab Ozogamicin, INO | Sheng-Li Xue, MD, Jining Medical University, The Second People's Hospital of Huai'an, First Affiliated Hospital Bengbu Medical College, Affiliated Hospital of Nantong University, Suzhou Hospital of Traditional Chinese Medicine, Northern Jiangsu People's Hospital | ALL, MRD-positive, Hematopoietic Stem Cell Transplantation | 08/25 | 08/25 | | |
NCT03984968: CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia |
|
|
| Recruiting | 1/2 | 27 | RoW | CD19 CAR-T cells infusion combined with feeding T cells (FTCs) | The First Affiliated Hospital of Soochow University | Acute Lymphoblastic Leukemia, Adult B-Cell | 06/25 | 12/25 | | |
NCT05470777: CD22/CD19 CAR-T and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL |
|
|
| Recruiting | 1/2 | 35 | RoW | CD22/CD19 CAR T and auto-HSCT "sandwich" strategy | The First Affiliated Hospital of Soochow University, National Natural Science Foundation of China(Grant No. 81970138), Jiangsu Province Natural Science Foundation of China (Grant No. BK20210091), Jining Medical University, The Second People's Hospital of Huai'an, First Affiliated Hospital Bengbu Medical College, Northern Jiangsu People's Hospital, Affiliated Hospital of Nantong University, Suzhou Hospital of Traditional Chinese Medicine | B-cell Acute Lymphoblastic Leukemia | 12/25 | 12/25 | | |
NCT03064269: CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia |
|
|
| Recruiting | 1 | 10 | RoW | CD19 CAR-T cells | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd, The First Affiliated Hospital of Soochow University | B-cell Acute Lymphocytic Leukemia | 12/24 | 12/25 | | |
NCT06507514: Blinatumomab and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL |
|
|
| Recruiting | 1 | 4 | RoW | blinatumomab and auto-HSCT "sandwich " strategy | The First Affiliated Hospital of Soochow University | B-cell Acute Lymphoblastic Leukemia | 04/28 | 04/30 | | |
NCT04146870: Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation |
|
|
| Recruiting | N/A | 200 | RoW | not have | The First Affiliated Hospital of Soochow University | Nutrition, Hematopoietic Stem Cell Transplantation | 12/24 | 12/24 | | |
NCT05772273: PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT |
|
|
| Recruiting | N/A | 43 | RoW | Azacitidine, Donor lymphocyte infusion, Camrelizumab | The First Affiliated Hospital of Soochow University, Jiangsu HengRui Medicine Co., Ltd. | Acute Myeloid Leukemia | 07/25 | 12/25 | | |
| Recruiting | N/A | 36 | RoW | cladribine, cytarabine,venetoclax | The First Affiliated Hospital of Soochow University, Jining Medical University, The Second People's Hospital of Huai'an, First Affiliated Hospital Bengbu Medical College, Northern Jiangsu People's Hospital, Affiliated Hospital of Nantong University, Suzhou Hospital of Traditional Chinese Medicine | Acute Lymphoblastic Leukemia | 10/25 | 10/25 | | |
